Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: MT2017-45: CAR-T Cell Therapy for Heme Malignancies [Phase 2]
Phase 2 trial MT2017-45 CAR-T cell therapy for hematologic malignancies has an active-not-recruiting status with results posted as of 2026-0…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies [Phase 1]
Phase 1 clinical trial evaluating a CD70-directed CAR T-cell therapy for pediatric hematologic malignancies is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2026-01-23Clinical Trial Update: Erwinase Master Treatment Protocol
This update notes that the Erwinase master treatment protocol for acute lymphoblastic leukemia is no longer available.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia [Phase 1]
A Phase 1 clinical trial update describing CD19 CAR-T cell therapy for adults with relapsed or refractory CD19-positive acute lymphoblastic …
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents [Phase 3]
This document provides an update on a Phase 3 clinical trial evaluating treatment for newly diagnosed acute lymphoblastic leukemia in childr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases [Phase 2]
Phase 2 clinical trial evaluating a cord blood transplant using cyclophosphamide, fludarabine, and total-body irradiation in high-risk hemat…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Evaluation of the Efficacy of Ponatinib in Ph+ ALL in the Real-world
This clinical trial update aims to assess the real-world efficacy of ponatinib in Philadelphia chromosome-positive acute lymphoblastic leuke…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Robot Rehab: AAI With Robot During Inpatient Pediatric Rehab [NA]
This completed clinical trial from the University of Nebraska evaluated robot-assisted rehabilitation integrated with animal-assisted interv…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children. [NA]
ClinicalTrials.gov entry for NCT02862652 reports a completed study investigating the role of microparticles and tissue factor in the pro-thr…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of Revumenib and Mezigdomide in People With Leukemia [Phase 1, Phase 2]
Clinical trial update describing a Phase 1/2 study of Revumenib and Mezigdomide for various forms of leukemia, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
A clinical trial update describing a study to identify barriers to allogeneic hematopoietic stem cell transplantation in patients with newly…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies
The Orca-T Expanded Access Program study for patients with advanced hematologic malignancies has a status update. The study is temporarily n…
-
EMA approval · 2026-01-15EMA Authorised: Blincyto (blinatumomab) — Amgen Europe B.V.
The EMA authorised Blincyto (blinatumomab) by Amgen Europe B.V. for precursor cell lymphoblastic leukemia/lymphoma, designated as an orphan …
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study) [Phase 2]
Phase II randomized trial evaluating whether an augmented reality game can reduce postoperative opioid use in pediatric cancer surgery patie…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
A pharmacogenomic association study sponsored by the University of Geneva is enrolling Indian children with acute lymphoblastic leukemia to …
-
CLINICAL_TRIALS other · 2026-01-15Clinical Trial Update: Gastric Content Ultrasound Monitoring Prior to Extubation in Critically Ill Children
The pediatric clinical trial evaluating gastric content ultrasound monitoring prior to extubation in critically ill children has been termin…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Influences of High-fiber, Organic Whole-food Formula on the Gut Microbiome in Critically Ill Children [NA]
This clinical trial update reports on a completed study evaluating the impact of a high-fiber, organic whole-food formula on the gut microbi…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL [Phase 1]
Phase 1 trial of CAR-20/19-T cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Optimizing Recovery in Pediatric ALL Survivors: A Training Comparison [NA]
A completed clinical trial comparing training interventions to optimize recovery in pediatric acute lymphoblastic leukemia survivors.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 clinical trial evaluating ruxolitinib in combination with chemotherapy for adolescents and young adults with Philadelphia-like acute…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL [Phase 1]
Phase 1 pharmacokinetic and safety study of MRX-2843 in adolescents and adults with relapsed/refractory acute myeloid leukemia, acute lympho…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL) [Phase 1]
This clinical trial update indicates completion of a Phase 1 study of intravenous blinatumomab in Japanese adults with newly diagnosed Phila…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
A clinical trial update indicates that a study examining trajectories and predictors of chemotherapy-induced peripheral neuropathy in childr…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States
This update describes ongoing financial distress experienced by families during treatment for pediatric acute lymphoblastic leukemia in the …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy. [NA]
This clinical trial update notes that a pediatric study evaluating laughter and fun yoga as adjunctive pain relief after chemotherapy in chi…